Questions Answered on ART Safety and Tolerability in Aging Patients and Populations With Cardiometabolic Toxicities

Hear from expert faculty as they answer questions and discuss key considerations when evaluating potential ARV-related toxicities in special populations, including aging patients and populations with cardiometabolic toxicities.